|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Depreciation and amortization | |||
| Accretion of note payable discount | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | |||
| Accretion of note payable discount | |||
| Non-cash interest expense | |||
| Change in fair value of digital assets | |||
| Impairment of goodwill | |||
| Stock based compensation | |||
| Non-cash professional fees | |||
| Non-cash lease expense | |||
| Reversal of contingent liability | |||
| Modification of related party debt | |||
| Provision for bad debt and write-off on uncollectable accounts | |||
| Provision for inventory reserve and write-off | |||
| Impairment of intangibles | |||
| Foreign exchange (gain)/loss | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Inventory | |||
| Prepaid expenses | |||
| Deferred revenue | |||
| Due to related parties | |||
| Accounts payable and accrued liabilities | |||
| Net cash used in operating activities | |||
| Investing activities | |||
| Purchase of property and equipment | |||
| Purchase of digital assets | |||
| Sale of digital assets | |||
| Cash used in acquisition | |||
| Net cash used in investing activities | |||
| Financing activities | |||
| Proceeds from issuance of common stock (ATM), net of fees | |||
| Proceeds from issuance of class B common stock pursuant to Initial Public Offering, net of issuance costs | |||
| Proceeds from issuance of convertible notes | |||
| Proceeds from related party loans | |||
| Proceeds from issuance of promissory notes and warrants | |||
| Proceeds from exercise of warrants | |||
| Proceeds from issuance of original issue discount notes | |||
| Proceeds from pre-funded warrants, net of fees | |||
| Funds provided for related party notes receivable | |||
| Payments for deferred offering costs | |||
| Payments on notes payable | |||
| Repayments of loans due to related parties | |||
| Net cash provided by financing activities | |||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Net increase (decrease) in cash | |||
| Cash and cash equivalents at beginning of year | |||
| Successor | |||
| Total cash and cash equivalents at beginning of year | |||
| Cash and cash equivalents at the end of year | |||
| Supplementary cash flow disclosure | |||
| Interest paid | |||
| Shares issued for conversion from convertible note payable | |||
| Unpaid deferred offering costs | |||
| Debt to equity conversion | |||
| Digital assets received in connection with pre-funded warrants | |||
| Issuance of debt in connection with acquisition | |||
| Issuance of warrants in connection with acquisition | |||
| Fair value of assets acquired |
Loading...